Tian S first explored the oncogenic role of GGT7 in HCC and confirmed that the expression of GGT7 mRNA in hepatocellular carcinoma tissues was greater than that in normal liver samples and that high expression of GGT7 mRNA was associated with poorer overall survival (OS) and poorer disease‐free survival (DFS) and that GGT7 may be a promising biomarker for predicting the survival of patients with HCC [15]. The gene discussed is GGT7; the disease is hepatocellular carcinoma.